The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(Hydroxymethyl)-3-(propan-2-ylidene)-5-((4-p-tolyl-1H-1,2,3-triazol-1-yl)methyl)dihydrofuran-2(3H)-one ID: ALA5084886
PubChem CID: 166634190
Max Phase: Preclinical
Molecular Formula: C18H21N3O3
Molecular Weight: 327.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)=C1CC(CO)(Cn2cc(-c3ccc(C)cc3)nn2)OC1=O
Standard InChI: InChI=1S/C18H21N3O3/c1-12(2)15-8-18(11-22,24-17(15)23)10-21-9-16(19-20-21)14-6-4-13(3)5-7-14/h4-7,9,22H,8,10-11H2,1-3H3
Standard InChI Key: HMYUCLFAJHYACP-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
26.5205 -4.9957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3455 -5.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9367 -4.2834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5996 -5.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4246 -5.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6815 -5.0033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0121 -4.5166 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.4664 -4.7495 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.9088 -6.4554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5723 -7.2088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1003 -5.7082 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.3527 -3.5711 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.1702 -3.4890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3458 -2.6830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6335 -2.2668 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.0176 -2.8158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.0984 -2.3528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7635 -2.8429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5183 -2.5117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.6092 -1.6909 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9393 -1.2022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.1872 -1.5360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7294 -6.3702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3641 -1.3582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 2 1 0
2 4 1 0
6 8 2 0
5 9 2 0
9 10 1 0
1 11 1 0
3 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
14 17 1 0
9 23 1 0
20 24 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 327.38Molecular Weight (Monoisotopic): 327.1583AlogP: 2.27#Rotatable Bonds: 4Polar Surface Area: 77.24Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.15CX LogD: 3.15Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.69Np Likeness Score: 0.07
References 1. Elhalem E, Bellomo A, Cooke M, Scravaglieri A, Pearce LV, Peach ML, Gandolfi Donadío L, Kazanietz MG, Comin MJ.. (2021) Design, Synthesis, and Characterization of Novel sn -1 Heterocyclic DAG-Lactones as PKC Activators., 64 (15.0): [PMID:34279947 ] [10.1021/acs.jmedchem.1c00739 ]